PDCD1 and neoplasm: The model allowed to assess cytokine expression together with anti–PD-1–mediated T-cell activation and subsequent tumor cell death by fluorescence cell imaging and to explore the efficacy of a combination therapy with cyclin-dependent kinase (CDK)4/6 inhibitors [99,100].